Clinical trials
Completed Phase 1 Thalassemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 4 |
| Hangzhou Zede Pharma-Tech Co., Ltd. | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 1 |
| Catherine Bollard | 1 |
| Duke University | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thalassemia | 14 |
| Anemia, Sickle Cell | 4 |
| Iron Overload | 2 |
| Anemia | 1 |
| Anemia, Diamond-Blackfan | 1 |
| Hemochromatosis | 1 |
| Hemoglobinopathies | 1 |
| Hemolysis | 1 |
| Hypertension, Pulmonary | 1 |
| Immunologic Deficiency Syndromes | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.